To platform or not to platform: Strategic considerations for antibody formulation in early clinical development.

Formulation development aims at finding the most stabilizing conditions for a particular therapeutic protein molecule. Typically, various combinations of buffer type, pH, and additional excipients are experimentally tested at different concentrations…

Preview only. Read the full abstract at the source